Hypokalemia News and Research

RSS
Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Once-daily prescription medicine for COPD now available throughout the U.S.

Once-daily prescription medicine for COPD now available throughout the U.S.

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Excessive intake of cola and honey can cause fainting and arrhythmia symptoms, shows study

Excessive intake of cola and honey can cause fainting and arrhythmia symptoms, shows study

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Boehringer Ingelheim updates HCPs, patients on COMBIVENT RESPIMAT Inhalation Spray

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Genetic testing services for rare neurological disorders launched by Athena Diagnostics

Benefits of diastolic function improvement in heart failure questioned

Benefits of diastolic function improvement in heart failure questioned

Long-term treatment with spironolactone improves left ventricular diastolic function in HF patients

Long-term treatment with spironolactone improves left ventricular diastolic function in HF patients

Cubist seeks FDA sNDA approval for ENTEREG to accelerate GI recovery

Cubist seeks FDA sNDA approval for ENTEREG to accelerate GI recovery

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Eplerenone shown to reduce cumulative heart failure hospitalisations

Eplerenone shown to reduce cumulative heart failure hospitalisations

Pendrin a possible new target for diuretic therapy

Pendrin a possible new target for diuretic therapy